Plan your participation in the ESMO Targeted Anticancer Therapies Congress 2024, taking place from 26 to 28 February 2024 in Paris, France.

ESMO TAT offers participants a glimpse into the future of anticancer therapies, focusing on promising new targets and agents with a particular emphasis on early drug development.

Recognising the unique opportunities that this event creates as a forum connecting all oncology stakeholders, ESMO TAT 2024 will underpin the vital collaboration required to improve the outcomes for cancer patients worldwide.

Speakers from both academia and industry will participate in an expanded programme, including four new joint ESMO-Industry special sessions addressing drug development, methodological, regulatory, strategic financing and investment issues, offering attendees a fresh, wide-ranging perspective on the development of innovative cancer therapeutics and their optimal implementation.

Empowering the expression of views of stakeholders beyond academia, such as industry, investors and regulators, will supplement the rich educational and scientific content of ESMO TAT 2024 in the fascinating arena of therapeutic innovation.